ALKERMES | ALKS - درآمد حاصل از بهره





درآمد حاصل از بهره تغییر دادن تاریخ
AbbVie USD 72M 10M 2025-09
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
ALKERMES USD 11.94M 853K 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 88M 15M 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.12 0.17 2025-09
Merck USD 96M 27M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Otsuka Holdings JPY 10.49B 396M 2024-06
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09